New York Conference Raises Awareness for Gaucher Disease
As a culmination of Gaucher Awareness Month, on October 30,... Read more
Clinical Trial for Gaucher Disease Type 3
Sanofi Genzyme’s Phase 2 Clinical Trial to Evaluate Oral Substrate... Read more
[Video] Brian’s Story: Finding a Treatment for Type 1 Gaucher
Brian Berman is president and chief executive officer of the... Read more
Gaucher Disease and Parkinson: An Opportunity to Participate in a Study
Researchers have linked Gaucher disease to a slightly increased risk... Read more
Meet the Garay Family: Gaucher Disease Patient Journey
The Garay family has three children: Diego, 9, Sienna, 5,... Read more
Meet Lauren: Gaucher Disease Patient Journey
This month we are introducing you to several faces of... Read more
Sanofi Genzyme announces “Seven Tests for Managing Gaucher”
It’s important to monitor Gaucher disease with regular assessments. For... Read more
Can Gaucher Disease Carriers Have Symptoms?
The National Gaucher Foundation has received several inquiries from people... Read more
The 25th Anniversary of FDA Approval of ERT
In 1991, the U.S. Food and Drug Administration (FDA) approved... Read more
NGF Mourns the Loss of Dr. Roscoe Brady
Summary: The National Gaucher Foundation today mourns the passing of... Read more
